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ABSTRACT
Approximately 240 million people worldwide are infected by Schistosoma. In Brazil, 
one of the main intermediate hosts of this parasite is Biomphalaria glabrata snails. The early 
detection of larval stages in intermediate hosts is an important challenge to public health, 
but it also represents an opportunity as a new alternative to indicate earlier natural infections 
before cercariae differentiation and emergence. In this context, we demonstrated that PCR 
amplification of a 28S gene fragment from the parasite does demonstrate S. mansoni infection 
in snails 14 days post infection. This conventional polymerase chain reaction amplified 
clear bands and was able to detect parasitic infection in the intermediate host B. glabrata 
under experimental conditions. However, we reinforce that this approach requires deeper 
investigations and further comparisons to confirm its specificity and sensitivity in earlier 
time points after miracidia infection. This approach has relevant potential as an effective 
molecular-based strategy for the monitoring of schistosomiasis transmission.
KEYWORDS: Schistosoma mansoni. Biomphalaria glabrata. Molecular diagnosis. 
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INTRODUCTION
Approximately 240 million people worldwide are infected by Schistosoma 
trematodes. In Brazil, one of the main intermediate hosts of this parasite is the 
Biomphalaria glabrata snail1-3. The early detection of larval stages in intermediate 
hosts is an important challenge to public health, but it has the potential to detect 
positive snail hosts before the emergence of cercariae, thus becoming a new 
alternative to detect intramollusc forms4,5, revealing reliable parasite prevalence 
rates. The objective of this study is to evaluate the prepatent detection of S. mansoni 
DNA in B. glabrata snails using the polymerase chain reaction (PCR) 14 days after 
snails exposed to miracidia. Furthermore, we aimed to standardize the entire process, 
evaluating the specificity of the primers in two groups of snails. 
MATERIAL AND METHODS
Laboratory maintenance of the S. mansoni experimental cycle
The laboratory cycle of S. mansoni has been implemented more than 30 years 
ago at the Instituto de Medicina Tropical de Sao Paulo, using a S. mansoni strain 
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obtained in Belo Horizonte, Minas Gerais, Brazil (BH 
strain), as well as a B. glabrata strain (GIDE), collected in 
Campinas, Sao Paulo, Brazil.
Since the beginning, the S. mansoni cycle was 
maintained through periodic infections of hamsters 
(Mesocricetus auratus) and B. glabrata snails at the 
Laboratory of Schistosomiasis Immunopathology 
(LIM-06). Hamsters were kept in the animal house of of 
Instituto de Medicina Tropical de Sao Paulo, Universidade 
de Sao Paulo, Brazil, and all the experiments followed 
the Ethical Principles in Animal Experimentation of the 
Brazilian College of Animal Experimentation (CEP IMT-
2011/096).
Infection of B. glabrata by S. mansoni
Approximately 30 miracidia were obtained from a 
laboratory cycle of S. mansoni and were counted on Kline 
plates. Ten B. glabrata (BH) snails were infected and 
compared to ten non-infected snails to evaluate the primers’ 
specificity to S. mansoni DNA, and the presence of spurious 
non-specific bands derived from the snail host. A total 
of ten B. glabrata snails were exposed to approximately 
30 miracidia and had their head-foot portions removed 
14 days after this exposure. DNA was extracted soon after 
removing the snail’s head and foot, using the QIAamp® 
DNA Mini Kit (QIAGEN Inc., Hilden, USA), following 
the manufacturer’s instructions. DNA was quantified in 
a Nanodrop DR 1000 Spectrophotometer V3.8® (Thermo 
Fisher Scientific, Delaware,USA).
Amplification of S. mansoni DNA from primary 
sporocysts
PCR amplification was performed with the 
fo l lowing  S.  mansoni - spec i fic  pr imers :  SmF 
(5’-GAGATCAAGTGTGACAGTTTTGC-3’) and SmR 
(5’-25ACAGTGCGCGC GTCGTAAGC-3’), targeting the 
parasite 28S rDNA , yielding a 350-base pairs amplicon, as 
previously described by Sandoval et al.6.
PCR amplifications were performed in a final volume 
of 25 μL containing 2.5 μL 10 X reaction buffer, 3 mM 
MgCl2, 0.5 mM of each dNTP, 0.2 mM of each primer, 
2.5 U of Platinum Taq DNA polymerase (Invitrogen TM 
Life Technologies, Carlsbad, CA, USA) and 1 μL of DNA. 
The amplification consisted of 35 cycles, as follows: 94 °C 
for 20 s, 65 °C for 20 s, and 72 °C for 30 s. Amplicons 
were evaluated in 2% SYBR-safe-stained agarose gels 
and visualized under UV lights. DNA derived from adult 
S. mansoni worms (90 ng) and ultrapure Milli-Q water 
were used as positive and negative controls, respectively.
The possibility of samples contamination was minimized 
by the physical separation of rooms for DNA extraction 
and DNA amplification and by using laminar flow hoods, 
ultraviolet light chambers, and sterile, disposable laboratory 
materials including pipette filter tips.
RESULTS AND DISCUSSION
This study evaluated infection in the intermediate host 
by using a molecular biology technique.The visualization 
of the expected size amplicons, corresponding to 
Schistosoma mansoni 28S rDNA gene showed single 
amplicons for the positive control as well as for the 
infected snails, suggesting its specificity to the parasite 
DNA; in addition, no bands were seen when DNA from 
the non-infected snails or water were used as templates.
The amplification products of S. mansoni DNA extracted 
together with DNA from the snail host showed clear and 
specific bands 14 days after miracidia infection, indicating 
that the lower mass of sporocyst-derived DNA was enough 
to provide positive results (Figure 1).
Detection of Schistosoma DNA in the prepatent period, 
with different parasite loads, was first described by Jannotti-
Passos et al. in 19975, using a tandem repeated sequence 
of the parasite genome as the amplification target region. 
Subsequently, the same group reported the molecular 
identification of the parasite, targeting a mitochondrial 
DNA repeat in S. mansoni that allowed its detection in 
infected B. glabrata, with absence of non-specific (spurious) 
bands. This result points to the selectivity and specificity of 
this marker in the previous identification of infected snail 
hosts4,7. Since then, other studies aimed at performing the 
molecular diagnosis of infection in intermediate hosts have 
been developed and employed the loop-mediated isothermal 
amplification4,5,8.
Currently, the Brazilian surveillance control program 
recommends a conventional method to diagnose S. mansoni 
infections, in which snails suspected of being infected are 
exposed to light to stimulate cercariae release9. Cercariae 
are usually observed approximately 40 days after miracidia 
infection, at the end of this parasitic asexual cycle3.
The implementation of sensitive diagnostic tools to 
monitor the parasitic infection status in humans, mammalian 
reservoirs and intermediate hosts is part of the strategies 
discussed and recommended by WHO10.
Thus, the combination between traditional and 
molecular methods will help to improve the malacological 
surveillance of Schistosomiasis mansoni, especially in areas 
of low endemicity.
This study corroborates this point of view by improving 
diagnosis in the prepatent stage of infection in snails.
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Schistosomiasis is a chronic infection that may not 
progress to a severe form but can trigger debilitating 
sequelae that are secondary to parasitism11. Therefore, 
surveillance is critical in endemic areas. Nevertheless, 
considering that most infected snails can die during the 
vector surveillance process and that conventional techniques 
are efficient only for live snails after the completion of the 
period necessary for cercariae emergence, the prevalence of 
infection can be underestimated. These factors emphasize 
the need of a correct diagnosis prior to this stage, especially 
in areas of low endemicity, in which infections generally 
present low parasite loads5,12,13.
It is known that B. glabrata snails are the most 
susceptible intermediate host of this trematode compared 
to other natural snail hosts, and the implementation of 
sensitive diagnostics is a crucial and valuable tool to monitor 
parasitic infection status in humans, mammalian reservoirs, 
and intermediate snail hosts.
CONCLUSION
The results presented here reinforce that conventional 
PCR can be used to detect the presence of S. mansoni 
infection in the prepatent period, suggesting that this 
methodology is a sensitive and specific tool that is able 
to detect the parasite infection in intermediate hosts 
approximately 15 days before the traditional techniques.
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Figure 1 - The 350 bp amplification product from S. mansoni 28S rDNA gene using as template, DNA extracted from B. glabrata 
snails 14 days after their exposure to ~ 30 miracidia (1a to 10a) and B. glabrata snails not exposed to experimental infection (1b 
to 9b). 11a: negative control (ultrapure Milli-Q sterile water); 10b: positive control (DNA from adult S. mansoni worms). Molecular 
weight marker: 50 bp DNA ladder (Invitrogen TM Life Technologies Carlsbad, CA, USA).
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